Comparison of subsequent infusion hypersensitivity reactions to paclitaxel using two different infusion strategies

Purpose The purpose of this study was to compare the incidence of rescue medication utilization with up to 3 subsequent doses of paclitaxel in patients who underwent an infusion rate escalation versus those who continued on the standard infusion rate after experiencing an initial paclitaxel infusion hypersensitivity reaction (HSR) requiring rescue medications. Methods A retrospective, single-center review was conducted on patients who experienced a paclitaxel infusion HSR requiring rescue medications to their first or second lifetime dose of paclitaxel. Results A total of 99 patients were included for analysis, and from this group, 22 patients were continued on the standard infusion rate, while 77 patients were changed to an infusion rate escalation. The rate of subsequent rescue medication utilization was 5% in patients who were continued at the standard infusion rate versus 23% in patients who were changed to an infusion rate escalation (p = 0.064). The incidence of subsequent rescue medication utilization was unrelated to disease stage (p = 0.39), the paclitaxel dosing regimen (p = 0.99), or a diagnosis of asthma (p = 0.99). Conclusion This single-center, retrospective study suggests that while not statistically significant, there was a potentially clinically meaningful increase in the rate of subsequent rescue medication utilization in patients who were changed to an infusion rate escalation compared to those who continued on the same standard infusion rate after experiencing an initial HSR to paclitaxel.

Automated summary

The purpose of this study was to compare the incidence of rescue medication utilization with varying doses of paclitaxel in patients who experienced a hypersensitivity reaction and required rescue medications. The results indicated a potentially meaningful increase in rescue medication utilization in patients who underwent an infusion rate escalation compared to those who continued on the standard infusion rate. However, there was no significant correlation between rescue medication utilization and disease stage, dosing regimen, or asthma diagnosis.